{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:47:28Z","timestamp":1773085648735,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.10.036","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T15:22:02Z","timestamp":1163517722000},"page":"1534-1543","source":"Crossref","is-referenced-by-count":39,"title":["Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis"],"prefix":"10.1016","volume":"25","author":[{"given":"E.","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Goldsmith-Pestana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Travi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McMahon-Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.vaccine.2006.10.036_bib1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int J Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JCM.39.2.560-563.2001","article-title":"Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology","volume":"39","author":"Solano-Gallego","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.10.036_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","article-title":"Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies","volume":"64","author":"Travi","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.10.036_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.10.036_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vetpar.2004.12.002","article-title":"Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate","volume":"128","author":"Pasa","year":"2005","journal-title":"Vet Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.10.036_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/vr.156.11.346","article-title":"Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin","volume":"156","author":"Pennisi","year":"2005","journal-title":"Vet Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2006.10.036_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","volume":"57","author":"Alvar","year":"2004","journal-title":"Adv Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.036_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(05)70085-2","article-title":"Recombinant DNA-derived leishmania proteins: from the laboratory to the field","volume":"5","author":"Kubar","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2006.10.036_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"22","key":"10.1016\/j.vaccine.2006.10.036_bib17","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.10.036_bib18","series-title":"Third World Congress on Leishmaniasis","first-page":"178","article-title":"Immunization with H1 and HASPB1 leishmania proteins protect dogs against experimental canine leishmaniasis","author":"Moreno","year":"2005"},{"issue":"45","key":"10.1016\/j.vaccine.2006.10.036_bib19","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2006.10.036_bib20","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2006.10.036_bib21","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2006.10.036_bib22","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.vaccine.2005.12.039","article-title":"Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum","volume":"24","author":"Poot","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2006.10.036_bib23","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1128\/IAI.69.11.6776-6784.2001","article-title":"Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8","volume":"69","author":"Colmenares","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.10.036_bib24","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1128\/IAI.71.6.3172-3182.2003","article-title":"Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection","volume":"71","author":"Colmenares","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib25","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/IAI.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis","volume":"63","author":"Soong","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/expr.1996.0100","article-title":"T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure","volume":"84","author":"Coutinho","year":"1996","journal-title":"Exp Parasitol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.036_bib27","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/IAI.66.7.3100-3105.1998","article-title":"Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis","volume":"66","author":"Haberer","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0035-9203(88)90510-X","article-title":"Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment","volume":"82","author":"Mancianti","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/3283159","article-title":"Canine leishmaniasis: pathological and ecological factors influencing transmission of infection","volume":"77","author":"Abranches","year":"1991","journal-title":"J Parasitol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2006.10.036_bib30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.micinf.2005.04.009","article-title":"Analysis of ribosomal DNA internal transcribed spacer sequences of the Leishmania donovani complex","volume":"7","author":"Kuhls","year":"2005","journal-title":"Microbes Infect"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-2427(03)00049-7","article-title":"Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen","volume":"93","author":"Fujiwara","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-2478(03)00020-8","article-title":"Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications","volume":"86","author":"Cordeiro-da-Silva","year":"2003","journal-title":"Immunol Lett"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.10.036_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-2427(02)00311-2","article-title":"IgG subclass responses in a longitudinal study of canine visceral leishmaniasis","volume":"91","author":"Quinnell","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.10.036_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-2427(01)00270-7","article-title":"Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis","volume":"79","author":"Leandro","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.10.036_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: Hallmarks for clinical status and tissue parasite density in brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","author":"Reis","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/319869","article-title":"Tissue cytokine responses in canine visceral leishmaniasis","volume":"183","author":"Quinnell","year":"2001","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.036_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpara.2004.10.015","article-title":"Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs","volume":"35","author":"Strauss-Ayali","year":"2005","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.10.036_bib41","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1365-2249.2001.01551.x","article-title":"Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis","volume":"124","author":"Kumar","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.036_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2006.10.036_bib44","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","article-title":"Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response","volume":"143","author":"Squires","year":"1989","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.10.036_bib45","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.036_bib46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.10.036_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(02)00134-4","article-title":"Cytokine expression during the outcome of canine experimental infection by Leishmania infantum","volume":"88","author":"Santos-Gomes","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.036_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.1997.56.522","article-title":"Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis","volume":"56","author":"Sundar","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.036_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine responses in Indian kala-azar before and after treatment","volume":"177","author":"Kenney","year":"1998","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2006.10.036_bib50","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.036_bib51","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"issue":"6552","key":"10.1016\/j.vaccine.2006.10.036_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2006.10.036_bib53","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses","volume":"9","author":"Stager","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2006.10.036_bib54","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"Stager","year":"2003","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.036_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.036_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.036_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.036_bib58","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.10.036_bib59","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.036_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0966-842X(98)01208-6","article-title":"Antibody-mediated protection against intracellular pathogens","volume":"6","author":"Casadevall","year":"1998","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.036_bib61","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.036_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1084\/jem.20052288","article-title":"Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity","volume":"203","author":"Woelbing","year":"2006","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.036_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.152.3.1047","article-title":"Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection","volume":"152","author":"Morris","year":"1994","journal-title":"J Immunol"},{"issue":"4804","key":"10.1016\/j.vaccine.2006.10.036_bib64","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib65","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.4049\/jimmunol.157.9.4068","article-title":"IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite","volume":"157","author":"Wynn","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.036_bib66","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.4049\/jimmunol.159.5.2409","article-title":"Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120","volume":"159","author":"Jankovic","year":"1997","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.10.036_bib67","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.161.9.4563","article-title":"CD40 ligand\/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge","volume":"161","author":"Gurunathan","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.10.036_bib68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T18:35:20Z","timestamp":1683657320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06011728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06011728"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}